is hims still selling compounded semaglutide cancels plans to sell GLP-1 pill after FDA backlash Hims & Hers Stock Plunges
Description
Eli Lilly now has a GLP-1 Diabetes approved treatment on the market under the Diabetes brand name, Mounjaro, that seems to be as if not more effective as Semaglutide in terms of weight loss when used for obesity
Discover why Canadians prefer this triple-agonist peptide over Semaglutide and Tirzepatide
The organising principle On average, insulin resistance tends to improve most through (1) movement, (2) body fat reduction where appropriate, and (3) reducing glucotoxicity

In 2025 Boccard partnered with a pharmaceutical manufacturer to design and deliver a complete GLP1 production installation supporting the clients expansion plan
